157 related articles for article (PubMed ID: 20227314)
1. Current concepts in the pathogenesis of urea cycle disorders.
Braissant O
Mol Genet Metab; 2010; 100 Suppl 1():S3-S12. PubMed ID: 20227314
[TBL] [Abstract][Full Text] [Related]
2. Hyperammonemia-induced toxicity for the developing central nervous system.
Cagnon L; Braissant O
Brain Res Rev; 2007 Nov; 56(1):183-97. PubMed ID: 17881060
[TBL] [Abstract][Full Text] [Related]
3. Ammonia toxicity to the brain.
Braissant O; McLin VA; Cudalbu C
J Inherit Metab Dis; 2013 Jul; 36(4):595-612. PubMed ID: 23109059
[TBL] [Abstract][Full Text] [Related]
4. Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, resulting in secondary cerebral creatine deficiency.
Braissant O; Cagnon L; Monnet-Tschudi F; Speer O; Wallimann T; Honegger P; Henry H
Eur J Neurosci; 2008 Apr; 27(7):1673-85. PubMed ID: 18380667
[TBL] [Abstract][Full Text] [Related]
5. Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine.
Braissant O
Mol Genet Metab; 2010; 100 Suppl 1():S53-8. PubMed ID: 20227315
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in urea cycle disorders: Findings from clinical and basic research.
Parmeggiani B; Vargas CR
Clin Chim Acta; 2018 Feb; 477():121-126. PubMed ID: 29203429
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of urea cycle dysfunction and altered brain energy metabolism on modulation of glutamate receptors and transporters in acute and chronic hyperammonemia.
Natesan V; Mani R; Arumugam R
Biomed Pharmacother; 2016 Jul; 81():192-202. PubMed ID: 27261594
[TBL] [Abstract][Full Text] [Related]
8. Glutamate transporter and receptor function in disorders of ammonia metabolism.
Butterworth RF
Ment Retard Dev Disabil Res Rev; 2001; 7(4):276-9. PubMed ID: 11754522
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of adjunct therapeutic hypothermia treatment for hyperammonemia and encephalopathy due to urea cycle disorders and organic acidemias.
Lichter-Konecki U; Nadkarni V; Moudgil A; Cook N; Poeschl J; Meyer MT; Dimmock D; Baumgart S
Mol Genet Metab; 2013 Aug; 109(4):354-9. PubMed ID: 23791307
[TBL] [Abstract][Full Text] [Related]
10. Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition.
Wells DL; Thomas JB; Sacks GS; Zouhary LA
Nutrition; 2014; 30(7-8):943-7. PubMed ID: 24985015
[TBL] [Abstract][Full Text] [Related]
11. Threshold for toxicity from hyperammonemia in critically ill children.
Ozanne B; Nelson J; Cousineau J; Lambert M; Phan V; Mitchell G; Alvarez F; Ducruet T; Jouvet P
J Hepatol; 2012 Jan; 56(1):123-8. PubMed ID: 21703182
[TBL] [Abstract][Full Text] [Related]
12. Severe hyperammonaemia in adults not explained by liver disease.
Walker V
Ann Clin Biochem; 2012 May; 49(Pt 3):214-28. PubMed ID: 22349554
[TBL] [Abstract][Full Text] [Related]
13. Ammonium metabolism in humans.
Adeva MM; Souto G; Blanco N; Donapetry C
Metabolism; 2012 Nov; 61(11):1495-511. PubMed ID: 22921946
[TBL] [Abstract][Full Text] [Related]
14. Fatal hyperammonemia after renal transplant due to late-onset urea cycle deficiency: a case report.
Bezinover D; Douthitt L; McQuillan PM; Khan A; Dalal P; Stene J; Uemura T; Kadry Z; Janicki PK
Transplant Proc; 2010 Jun; 42(5):1982-5. PubMed ID: 20620562
[TBL] [Abstract][Full Text] [Related]
15. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Virmani A; Gaetani F; Binienda Z
Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
[TBL] [Abstract][Full Text] [Related]
16. Urea cycle disorders in Thai infants: a report of 5 cases.
Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
[TBL] [Abstract][Full Text] [Related]
17. Progress and challenges in development of new therapies for urea cycle disorders.
Soria LR; Ah Mew N; Brunetti-Pierri N
Hum Mol Genet; 2019 Oct; 28(R1):R42-R48. PubMed ID: 31227828
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of urea cycle disorders: current global scenario.
Vaidyanathan K
Indian J Biochem Biophys; 2013 Oct; 50(5):357-62. PubMed ID: 24772957
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric manifestations in late-onset urea cycle disorder patients.
Serrano M; Martins C; Pérez-Dueñas B; Gómez-López L; Murgui E; Fons C; García-Cazorla A; Artuch R; Jara F; Arranz JA; Häberle J; Briones P; Campistol J; Pineda M; Vilaseca MA
J Child Neurol; 2010 Mar; 25(3):352-8. PubMed ID: 19684305
[TBL] [Abstract][Full Text] [Related]
20. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy.
Michalak A; Butterworth RF
Metab Brain Dis; 1997 Sep; 12(3):171-82. PubMed ID: 9346466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
